300 related articles for article (PubMed ID: 26079682)
21. Elevated levels of soluble Fas (APO-1, CD95), soluble Fas ligand, and matrix metalloproteinase-3 in sera from patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
Clin Rheumatol; 2007 Mar; 26(3):393-400. PubMed ID: 16972019
[TBL] [Abstract][Full Text] [Related]
22. Adult-onset Still's disease: still a diagnosis of exclusion. A nested case-control study in patients with fever of unknown origin.
Vanderschueren S; Hermans F; De Munter P; Knockaert D
Clin Exp Rheumatol; 2012; 30(4):514-9. PubMed ID: 22510428
[TBL] [Abstract][Full Text] [Related]
23. Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome.
Kasama T; Furuya H; Yanai R; Ohtsuka K; Takahashi R; Yajima N; Miwa Y; Kobayashi K
Clin Rheumatol; 2012 May; 31(5):853-60. PubMed ID: 22322207
[TBL] [Abstract][Full Text] [Related]
24. Clinical manifestations of Adult-onset Still's disease presenting with erosive arthritis: Association with low levels of ferritin and Interleukin-18.
Ichida H; Kawaguchi Y; Sugiura T; Takagi K; Katsumata Y; Gono T; Ota Y; Kataoka S; Kawasumi H; Yamanaka H
Arthritis Care Res (Hoboken); 2014 Apr; 66(4):642-6. PubMed ID: 24124073
[TBL] [Abstract][Full Text] [Related]
25. The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease.
Zou YQ; Lu LJ; Li SJ; Zeng T; Wang XD; Bao CD; Chen SL; Yang CD
Clin Biochem; 2008 May; 41(7-8):519-24. PubMed ID: 18261992
[TBL] [Abstract][Full Text] [Related]
26. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
[TBL] [Abstract][Full Text] [Related]
27. Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.
Chen X; Hu QY; Wang M; Jia J; Teng J; Sun Y; Cheng X; Ye J; Su Y; Shi H; Chi H; Zhou Z; Liu T; Wang Z; Wan L; Qiao X; Wang F; Wu X; Yang C; Liu HL
Rheumatol Int; 2022 Jan; 42(1):149-157. PubMed ID: 34499196
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
29. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
30. Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease.
Han JH; Suh CH; Jung JY; Nam JY; Kwon JE; Yim H; Kim HA
Arthritis Res Ther; 2015 Sep; 17(1):260. PubMed ID: 26385705
[TBL] [Abstract][Full Text] [Related]
31. Clinical relevance for circulating cold-inducible RNA-binding protein (CIRP) in patients with adult-onset Still's disease.
Fujita Y; Yago T; Asano T; Matsumoto H; Matsuoka N; Temmoku J; Sato S; Yashiro-Furuya M; Suzuki E; Watanabe H; Kawakami A; Migita K
PLoS One; 2021; 16(8):e0255493. PubMed ID: 34351954
[TBL] [Abstract][Full Text] [Related]
32. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis.
Rau M; Schiller M; Krienke S; Heyder P; Lorenz H; Blank N
J Rheumatol; 2010 Nov; 37(11):2369-76. PubMed ID: 20810496
[TBL] [Abstract][Full Text] [Related]
33. Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease.
Kim HA; Choi B; Suh CH; Han MH; Jung JY; Sayeed HM; Kim YW; Sohn S
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106835
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 6: a possible marker of disease activity in adult onset Still's disease.
Scheinberg MA; Chapira E; Fernandes ML; Hubscher O
Clin Exp Rheumatol; 1996; 14(6):653-5. PubMed ID: 8978961
[TBL] [Abstract][Full Text] [Related]
35. Potential role of adenosine deaminase in the diagnosis of adult-onset Still's disease.
Xun C; Zhao Y; Hu ZJ
Rheumatol Int; 2013 May; 33(5):1255-8. PubMed ID: 23096558
[TBL] [Abstract][Full Text] [Related]
36. [Ferritin levels in adult Still's disease].
Flatau E; Reichman N; Kaufman N
Harefuah; 1999 Sep; 137(5-6):200-1, 263, 262. PubMed ID: 10959321
[TBL] [Abstract][Full Text] [Related]
37. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
[TBL] [Abstract][Full Text] [Related]
38. Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
Di Benedetto P; Cipriani P; Iacono D; Pantano I; Caso F; Emmi G; Grembiale RD; Cantatore FP; Atzeni F; Perosa F; Scarpa R; Guggino G; Ciccia F; Giacomelli R; Ruscitti P
PLoS One; 2020; 15(7):e0235326. PubMed ID: 32645077
[TBL] [Abstract][Full Text] [Related]
39. Performance of the modified Systemic Manifestation Score for systemic juvenile idiopathic arthritis in Adult-onset Still's disease.
Zhu D; Meng J; Jia J; Wang M; Ma Y; Shi H; Sun Y; Liu H; Cheng X; Su Y; Ye J; Chi H; Liu T; Wang Z; Wan L; Zhou Z; Wang F; Chen X; Yang C; Hu Q; Teng J
Clin Rheumatol; 2023 Jan; 42(1):187-195. PubMed ID: 36028637
[TBL] [Abstract][Full Text] [Related]
40. Extremely High Serum Ferritin: An Instrumental Marker of Masquerading Adult-Onset Still's Disease with Hemophagocytic Syndrome.
Yamashita S; Furukawa NE; Matsunaga T; Hirakawa Y; Tago M; Yamashita SI
Am J Case Rep; 2017 Dec; 18():1296-1301. PubMed ID: 29208852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
